PT-141 (Bremelanotide): Molecular Mechanisms and Melanocortin Receptor Research
PT-141 (Bremelanotide) is a cyclic heptapeptide derived from Melanotan II that selectively targets MC3R and MC4R melanocortin receptor subtypes within the central nervous system, activating hypothalamic dopaminergic pathways through a mechanism entirely distinct from peripheral vasodilatory approaches. This article examines the molecular architecture, receptor pharmacology, and neuroendocrine signaling research surrounding this compound.